Do not stop or change your medication without speaking to a pharmacist or healthcare professional.
Permanently Discontinued

HUMIRA

ABBVIE CORPORATION

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is HUMIRA discontinued in Canada?

Yes. The manufacturer has reported to Health Canada that HUMIRA 40MG has been permanently discontinued (last updated October 31, 2026). It is not expected to come back, so talk to your pharmacist or doctor about an alternative.

Why is HUMIRA not available?

The reason the manufacturer reported: Business reasons.

Can I still get this?Possibly — same-ingredient product records found
StatusPermanently Discontinued
Same-ingredient products on file6 products
Affected strength40MG
Report last updated2026-10-31
Checked by MedShort2026-11-12

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Closest Matches

HUMIRA

ABBVIE CORPORATION

40MG · DIN 02458349

Same strengthSame dosage formSame routeNo current shortage

HADLIMA

SAMSUNG BIOEPIS CO., LTD

40MG · DIN 02533472

Same strengthSame dosage formSame routeNo current shortage

HADLIMA PUSHTOUCH

SAMSUNG BIOEPIS CO., LTD

40MG · DIN 02533480

Same strengthSame dosage formSame routeNo current shortage

HULIO

BIOCON BIOLOGICS CANADA INC

40MG · DIN 02502399

Same strengthSame dosage formSame routeNo current shortage

IDACIO

FRESENIUS KABI CANADA LTD

40MG · DIN 02502682

Same strengthSame dosage formSame routeNo current shortage

ABRILADA

PFIZER CANADA ULC

40MG · DIN 02511045

Same strengthSame dosage formSame routeNo current shortage

What this means

Does this mean I need to switch medications right away?

Not necessarily right away, but this product will not be returning to the market.

What should I do?

Talk to your pharmacist or prescriber about your options well before your current supply runs out.

DIN

02258595

Strength

40MG

Dosage Form

SOLUTION

Route

SUBCUTANEOUS

Active Ingredient

ADALIMUMAB

See all ADALIMUMAB products →

Shortage History